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Maternal inheritance of mutations in the GNAS1 gene is associated with obesity in humans, but the mecha-
nism involved is unknown. In this issue, Chen et al. (2009) have generated mice with brain specific deletion
of either the maternal or paternal allele to trace the origin of the phenotype.The characterization of genetic and exper-
imental syndromes of obesity in rodents
has played a major role in the identification
of the molecular components of energy
homeostasis over the last 15 years (Fried-
man, 2004). The finding that mutations in
many of these genes result in severe
obesity in humans has demonstrated
that these pathways, in particular the lep-
tin-melanocortin pathway, are highly
conserved across mammalian species.
There are a number of human genetic
syndromes where obesity occurs in asso-
ciation with developmental delay and
organ-specific abnormalities. In many
cases, significant progress has been
made in understanding the molecular
and cellular mechanisms underlying these
complex syndromes (for example in Bar-
det-Biedl Syndrome), but the mecha-
nisms whereby mutations in these specific
genes lead to obesity are only beginning to
emerge.
One such disorder is Albright hereditary
osteodystrophy (AHO). First described by
the American Endocrinologist Fuller Al-
bright in 1942, the characteristic features
are obesity, short stature, skeletal defects,
and subcutaneous calcification. AHO is an
autosomal dominantdisorder due to germ-
line mutations in the GNAS1 gene thatdecrease expression or function of Gsa
protein, which couples seven-transmem-
brane domain receptors to the cAMP-
generating enzyme adenylyl cyclase.
Several groups have shown that imprinting
plays a role in the pathogenesis of AHO
(Davies and Hughes, 1993), as the pres-
ence or absence of another phenotype,
multihormone resistance, in an affected
individual is determined by whether the
disease is inherited from the father or the
mother (Weinstein et al., 2002) (Figure 1).
Thus, patients who inherit the mutation
from their father develop AHO, whereas
patients who inherit the mutation from their
mother develop AHO and resistance to
a number of hormones including parathy-
roid hormone and thyroid stimulating
hormone.
Imprinting is an epigenetic phenomenon
affecting a small number of genes whereby
transcriptional silencing of one allele
(paternal or maternal depending on the
specific gene) results in partial or total
loss of expression. Differences in DNA
methylation appear to be critical in
both the initiation and maintenance of
imprinting. Gsa is imprinted in a tissue-
specific and developmental stage-specific
manner and expressed primarily from the
maternal allele in various hormone targetCell Metaboltissues. Maternal inheritance of GNAS1
mutations results in obesity and multihor-
mone resistance in humans, and knockout
of the maternal allele results in mice that
are obese with reduced sympathetic
nervous system (SNS) activity and energy
expenditure.
In this issue of Cell Metabolism, Wein-
stein and colleagues investigated whether
Gsa imprinting in the CNS accounts for
these parent-of-origin metabolic effects,
by generating mice with CNS-specific
disruption of the maternal (mBrGsKO) or
paternal (pBrGsKO) Gsa allele. Female
mice with loxP sites surrounding Gsa
exon 1 were mated with nestin-cre males
(which express cre recombinase in the
CNS) to generate mBrGsKO mice;
pBrGsKO mice were generated with recip-
rocal crosses. mBrGsKO mice gained
much more weight than controls after
6 weeks with an increase in fat mass,
whereas pBrGsKO showed no differences
in body weight or composition. In a series
of elegant experiments, the authors
showed that the weight gain was predom-
inantly attributable to reduced resting and
total energy expenditure (TEE) (normalized
for body weight) at ambient temperatures
(21C or 23C). In both males and females,
linear regressions of body weight versusism 9, June 3, 2009 ª2009 Elsevier Inc. 487
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to follow a line significantly
right-shifted compared to
controls. mBrGsKO mice
also had low total-activity
levels, and low ambulating
activity in males at 23C. In
contrast, energy expenditure
and activity levels were unaf-
fected in pBrGsKO mice.
Interestingly, food intake at
6, 8, and 12 weeks in
mBrGsKO mice and at 12
weeks in pBrGsKO mice was
similar to controls when
normalized to body weight.
Once obesity had developed,
mBrGsKO mice ate more
than controls (presumably to
maintain their higher body
weight), but as the authors
point out, increased food
intake is unlikely to account
for the obesity, as feeding effi-
ciency (weight gain/kcal
intake) was more than 2-fold
higher in mBrGsKO mice. Therefore,
Weinstein and colleagues have shown
that CNS-specific disruption of the
maternal (but not paternal) Gsa allele leads
to obesity primarily due to an effect on
energy expenditure.
As mBrGsKOs share some phenotypes
with melanocortin 4 receptor knockout
mice (with the notable exception being
hyperphagia), the authors went on to inves-
tigate the effects of intraperitoneal admin-
istration of the melanocortin agonist MTII
in mBrGsKO mice. They found that the
increase in resting energy expenditure
(REE) seen in controls (and in pBrGsKO)
following injection of MTII was reduced in
mBrGsKO mice as was the predicted
increase in REE after 4 days of high-fat
diet. Weinstein and colleagues found
evidenceof lower SNS activity inmBrGsKO
mice, with significantly reduced levels of
norepinephrine (NE) and its metabolite di-
hydroxyphenylglycol in brown adipose
tissue (BAT) and significantly reduced
Ucp1 (uncoupling protein 1) gene expres-
sion in BAT. Interestingly, mBrGsKO mice
had reduced heart rate and diastolic blood
pressure despite being severely obese,
a phenotype that is consistently seen
in MC4R-deficient mice and humans and
is likely tobeexplained by impairedsympa-
thetic nervous system activation. In
keeping with these observations, glucose
and insulin tolerance tests showed
mBrGsKO, but not pBrGsKO, mice to be
glucose intolerant and insulin resistant. In
the absence of obesity, young mBrGsKO
had significantly higher insulin levels
consistent with effects seen in rodents
and humans with disruption of melanocor-
tin signaling (Fan et al., 2000; Farooqi et al.,
2003).
The authors went on to show that Gsa
undergoes imprinting in the paraventricu-
lar nucleus of the hypothalamus (PVN),
a region known to be important for the
regulation of energy expenditure and
where MC4R-expressing neurons make
monosynaptic connections with pregan-
glionic sympathetic neurons. Therefore,
the data from this careful and comprehen-
sive series of experiments suggests that
the effects of melanocortin signaling
and Gsa on energy expenditure occur
through common pathways. As MC4R is
a G protein-coupled receptor, the most
intuitive conclusion would be
that Gsa mediates the effects
of MC4R activation on the
sympathetic nervous system
and thus on energy expendi-
ture, blood pressure, and
heart rate regulation.
However, more work will be
needed to dissect these
mechanisms and determine
the direction of these effects.
Of considerable interest,
mBrGsKO mice had an
appropriate anorectic res-
ponse to the melanocortin
agonist MTII, suggesting that
activation of MC4R may alter
food intake via a Gsa-inde-
pendent pathway. Alterna-
tively, MC4R could still de-
pend on Gsa for its anorectic
effect if Gsa was not subject
to imprinting in the brain
region involved. These stud-
ies further our understanding
of the role of Gsa in energy
homeostasis. They also add to a large
amount of data from many investigators
concerning the role of the melanocortin
system in mediating effectson food intake,
energy expenditure, and cardiovascular
regulation, which will have relevance for
the understanding of human disease and
for therapeutic strategies based on the
manipulation of melanocortin signaling.
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Figure 1. Parent of Origin Effects for GNAS1 Mutations
The paternal allele of GNAS1 is imprinted (poorly expressed—shown as a red
cross) in a target tissue (such as the PVN in the brain), so maternal transmission
(pink panel) of a null mutation (arrow) in AHO patients or mBrGsKO mice would
result in little or no Gsa expression and, therefore, would be associated with
obesity. In contrast, paternal transmission (blue panel) of a null mutation in
pBrGsKO mice should result in a similar level of Gsa expression to that found
in controls (because the mutation is on the imprinted allele) and should not be
associated with obesity.488 Cell Metabolism 9, June 3, 2009 ª2009 Elsevier Inc.
